EVERSANA

    OverviewSuggest Edit

    EVERSANA (previously known as Dohmen Life Science Services) is a provider of commercial solutions and patient support services to the life sciences industry. It offers regulatory and management consulting, research, medical communication, pharmacovigilance, marketing, revenue management, and other services.
    TypePrivate
    Founded2018
    HQMilwaukee, WI, US
    Websiteeversana.com
    Employee Ratings3.5
    Overall CultureB

    Latest Updates

    Employees (est.) (Dec 2021)2,004
    Job Openings212
    Cybersecurity ratingBMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at EVERSANA

    Jim Lang

    Jim Lang

    Chief Executive Officer
    Greg Skalicky

    Greg Skalicky

    Chief Revenue Officer
    Kelly Baker

    Kelly Baker

    Chief Financial Officer
    Mark MacNaughton

    Mark MacNaughton

    Chief Information Officer
    Mike Ryan

    Mike Ryan

    Executive Vice President, EMEA
    Danny Williams

    Danny Williams

    President, Channel Management
    Show more

    EVERSANA Office Locations

    EVERSANA has offices in Milwaukee, Amherst, Berkeley Heights, Boston and in 13 other locations
    Milwaukee, WI, US (HQ)
    190 N Milwaukee St
    Amherst, NH, US
    292 nh - 101
    Berkeley Heights, NJ, US
    400 Connell Dr #2000
    Boston, MA, US
    1000 Massachusetts Ave # 101
    Chesterfield, MO, US
    17877 Chesterfield Airport Rd
    Chicago, IL, US
    404 S Wells St
    Show all (18)

    EVERSANA Financials and Metrics

    Summary Metrics

    Founding Date

    2018
    Show all financial metrics

    EVERSANA Operating Metrics

    EVERSANA's Customers was reported to be 500 in Apr, 2021.
    Nov, 2020Dec, 2020Apr, 2021

    Customers

    500500

    Patient Records

    300 m

    Solutions

    3

    Trademarks

    6
    Show all operating metrics

    EVERSANA Acquisitions / Subsidiaries

    Company NameDateDeal Size
    Alkemy PartnersSeptember 09, 2020
    HVH Patient Precision AnalyticsJuly 15, 2020
    Cornerstone Research GroupOctober 31, 2019
    Seeker HealthOctober 03, 2018

    EVERSANA Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    83/100

    SecurityScorecard logo

    EVERSANA Online and Social Media Presence

    Embed Graph

    EVERSANA Company Culture

    • Overall Culture

      B

      71/100

    • CEO Rating

      A+

      80/100

    • Compensation

      A+

      100/100

    Learn more on Comparably

    EVERSANA News and Updates

    Q BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnership

    NEW YORK and CHICAGO, Nov. 8, 2021 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, today announced it has engaged EVERSANA™, the pioneer of next...

    Evoke Pharma and EVERSANA Announce Positive Findings from GIMOTI® Market Research Study

    Health care practitioners’ perception of nasal route of administration similar to IV; 92% intend to prescribe GIMOTI

    Evoke Pharma’s Commercial Partner EVERSANA, Receives PM360’s Trailblazer Initiative Award for Innovation in Healthcare Marketing for GIMOTI

    Award for “Spray Away” Campaign seeking to drive patient and provider awareness for the novel nasal spray treatment of symptoms of Diabetic Gastroparesis

    Evoke Pharma and EVERSANA Announce Support of The International Foundation for Gastrointestinal Disorders’ (IFFGD) August Gastroparesis Awareness Month

    Participating and Sponsorship in Upcoming Digestive Health Virtual Walk Participating and Sponsorship in Upcoming Digestive Health Virtual Walk

    EVERSANA™ expands global commercialization solutions with acquisition of Accelera Canada and its partner companies

    EVERSANA™, the pioneer of next-generation commercial services to the global life sciences industry, today announced the acquisition of Accelera Canada and its partner companies Patient Access Solutions, Podium Strategic Partners, Inc., and Advocacy Solutions.

    GENinCode announces major US commercialisation partnership with EVERSANA

    GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces its partnership with EVERSANA Life Sciences LLC ("EVERSANA") as its launch and commercialisation partner to access the United States market for the GENinCod…
    Show more

    EVERSANA Frequently Asked Questions

    • When was EVERSANA founded?

      EVERSANA was founded in 2018.

    • Who are EVERSANA key executives?

      EVERSANA's key executives are Jim Lang, Greg Skalicky and Kelly Baker.

    • How many employees does EVERSANA have?

      EVERSANA has 2,004 employees.

    • Who are EVERSANA competitors?

      Competitors of EVERSANA include Health Management Associates, Fishawack Health and Biopas.

    • Where is EVERSANA headquarters?

      EVERSANA headquarters is located at 190 N Milwaukee St, Milwaukee.

    • Where are EVERSANA offices?

      EVERSANA has offices in Milwaukee, Amherst, Berkeley Heights, Boston and in 13 other locations.

    • How many offices does EVERSANA have?

      EVERSANA has 18 offices.